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AND HEPATITIS C VIRUS AMONG VOLUNTARY BLOOD DONORS IN ABIA 
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Hepatitis B and C viruses are among the common infectious diseases of the world and constitute a major global 
health burden. Consequent upon their mode of transmission, thorough screening of blood has become absolutely 
necessary, making quick provision of safe blood rather difficult. This study aims at determining the sero-prevalence 
of hepatitis B and C viruses among voluntary blood donors in our centre. This was a hospital-based cross sectional 
study and was carried out at the blood bank of the teaching hospital, Aba, from June 2013 and December 2014. Five 
hundred and thirty consecutively recruited voluntary blood donors were screened for hepatitis B and hepatitis C 
virus infections. Hepatitis B virus infection was screened using hepatitis B surface antigen by ELISA, while 
hepatitis C virus infection was screened using anti-HCV antibodies by ELISA. The biodata of the donors were 
obtained. The prevalence of hepatitis infection among the blood donors was 51 (9.6%). HBsAg and ant-HCV were 
reactive in 7.26% and 1.5% of the study population respectively while co-infection was recorded in 0.74% of the 
donors. In conclusion, this study confirmed the presence of viral hepatitides among voluntary blood donors and 
these infections can be transmitted through blood in Aba, Nigeria.
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INTRODUCTION
Hepatitis B and C viral infections are among common 
infectious diseases of the world and constitute a major 
health burden (Eke et al, 2011). Globally, over 2 
billion people are infected with the HB virus and over 
400 million have chronic infection (Olokoba et al,
2009; Eke et al, 2011). Individuals with chronic 
infection have a high risk of liver cirrhosis and hepato 
cellular carcinoma which accounts for more than 1 
million deaths worldwide (Onwuakor et al, 2014; 
Blattacharyd et al, 2007). The prevalence of chronic 
hepatitis B infection varies greatly around the world 
and is relatively high in Africa, which has the second 
highest number of chronically HBV – infected 
individuals (Mbaawuaga et al, 2008). Hepatitis C virus 
Infection (HCV) is also common with estimated 3.9 
million persons infected with the virus globally (Shittu 
et al, 2014). HCV has its highest prevalence rate in 
Africa where it is the leading cause of liver cirrhosis 
and liver cell carcinoma (Olokoba et al, 2009; 
Elsheikh et al, 2007; Kleinman et al, 2003).
Diagnosis of HBV infection is through serological and 
virological markers. Hepatitis B surface antigen 
(HBsAg) is the hallmark of HBV infection and is the 
first serological marker to appear in acute HBV 
infection; and persistence of HBsAg for more than 6 
months suggests chronic HBV infection (Kao, 2008; 
Ejele and Ojule, 2003; Onwuakor et al, 2014). The 
transmission of HBV infection Nigeria is on the 
increase (Shittu et al, 2014). Common routes of 
transmission of HBV and HCV include unsafe blood
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transfusion, unprotected sexual contact, intravenous 
drug abuse, and unsafe injections (Adekanle et al,
2010; Olokoba et al, 2008; Shittu et al, 2014).
In blood banks, the screening for HBsAg is carried out 
routinely to detect HBV infection (Blattacharya et al,
2007), while antibodies to hepatitis C virus (anti-
HCV) are used to detect HCV infection (Olokoba et 
al, 2008).
Unfortunately, Nigeria is classified among the group 
of countries endemic for HBV infection with a current 
infected population of 18 million (Onwuakor et al., 
2014; Ojo and Anibijuwon, 2009). Despite the 
existence of a safe and effective vaccine, Nigeria has 
remained a hyperendemic area for HBV infection, 
with an estimated 12% of the population being chronic 
carriers (Jatau and Yabaya, 2009; Ejele and Ojule, 
2003). Acute symptoms of Hepatitis B virus infections 
have no specific treatments but supportive measures 
include proper bed rest, prevention of dehydration, 
maintenance of balanced diet, avoidance of alcoholic 
beverages and analgesics. (Savel and Andelman, 2005; 
Shittu et al., 2014). HBV infection can however be 
prevented by avoiding any contact with infected blood 
and body fluids including semen and vaginal 
secretions of infected individuals (Lindsley et al.,
1990).
Safe blood transfusion is inevitable in the prevention 
of HBV and HCV transmission. Studies have shown 
that international modes and standards for organizing 
blood banks and blood donations are not affordable in 
Sub-Saharan Africa and might not even be sustained 
where they exist (Shittu et al, 2014). It has been 
revealed that the low implementation of national 
policies for transfusion, organizational dysfunctions, 
inadequate financing and the lack of adequate blood 
screening equipment are among the several problems 
undermining the blood safety in Sub-Sahara Africa 
(Florent et al, 2012).
Getting safe blood is becoming increasingly difficult 
because of these blood borne viral hepatitides 
(Olokoba et al, 2009). Various studies have been 
carried out on the prevalence of hepatitis B surface 
antigen and HCV among blood donors in various parts 
of Nigeria (Umolu et al, 2005; Uneka et al, 2005; 
Lawal et al, 2009; Ado et al, 2010) but none have 
been reported in Aba, Abia State. Nigeria. This study 
was therefore carried out to determine the prevalence 
of hepatitis B and C virus infections among apparently 
healthy intending blood donors at Abia State 
University Teaching Hospital (ABSUTH), Aba, 
Nigeria.
MATERIALS AND METHODS 
Study Area/Setting: Study was carried out at the 
haematology department of Abia State University 
Teaching Hospital between June 2013 and December 
2014.
Ethical Consideration: Ethical approval was obtained 
from ethical committee of Abia State University 
Teaching Hospital Aba.   
Sampling technique and Sample Size: A total of five 
hundred and thirty (530) blood donors were randomly 
selected for the study.
Inclusion and Exclusion Criteria: The blood used 
for this research included voluntary and commercial 
donors aged between 18 and 65 years.
Sample Collection and Sample Analysis: Blood 
samples were collected and screened for HBsAg and 
HCV. About 3.0mls of venous blood was obtained 
from each donor aseptically into plain bottles. The 
samples were allowed to clot and retract after which 
serum was isolated by centrifugation for about 5 
minutes. The serum samples were then screened for 
HBV using rapid test ELISA kits (Acon Laboratories, 
USA) to detect hepatitis B surface antigen (HBsAg). 
Also the serum samples were screened for HCV using 
rapid test ELISA kits (Acon Laboratories, USA) to 
detect antibodies to hepatitis C virus (anti-HCV).
Statistical analysis: Data analysis was done using 
statistical package for social sciences (SPSS, version 
100). Comparison of means was done using the 
student – t test. The level of statistical significance was 
taken as p < 0.05.
RESULTS
A total of five hundred and thirty (530) blood donors 
were screened for hepatitis B and C virus infections. 
The age of the donors ranged from 18-65 years with a 
mean of 34.65.7 years. Majority of the donors were 
in the age group 30-39 years (Table 1).
Of the 530 blood donors, 509 (96.0%) were males and 
21 (3.96%) were females, giving a male to female 
ratio of 24.24:1 (Table 2). 
The prevalence of Hepatitis infections among the 
blood donors was 51 (9.6%). HBV infection was 
higher among males (6.70%) than females (0.56%). 
Similarly, the prevalence of HCV infection was higher 
among males 6 (1.13%) than the females 2 (0.37%). 
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Co-infection with HBV and HCV were more prevalent 
in the males 3 (0.56%) than in females 1 (0.18%). HBs 
Ag and anti-HCV were reactive in 7.26% and 1.50% 
of the study population respectively while co-infection 
was recorded in 0.74% of the intending donors (Table 
3). However, there was no significant relationship 
between them (P > 0.05).
The subjects within ages 20-29 years and 30 – 39 
years had the highest prevalence of HBV infection 
(2.23%) and (2.79%) respectively. The prevalence of 
HCV was 0.37% between ages 20-29 years and 0.56% 
for ages 30-39 years. Subjects within ages 30-39 years 
had the highest prevalence of co-infection while ages 
40-69 had no co-infection. The frequency of co-
infection is therefore very low (Table 4).
Table1: Age and gender distribution of Blood donors.








































Table 3: Gender distribution of Hepatitis infection among the subjects
Gender Overall no 
screened
No positive for HBsAg 
(%)
No. positive for 
HCV (%)
No. positive for 
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Table 4: Distribution of Hepatitis Infection in relation to the age groups of the subjects:
Age Gender Overall no 
screened
No positive for 
HBsAg (%)
No. reactive for 
HCV (%)






































It is well documented in medical literature that the 
transmission of viral hepatitides (HBV and HCV 
infection) can occur during blood transfusion (Ejele et 
al., 2005; Abdalla et al., 2005; Elfaki et al., 2008). 
Proper screening of every blood donor is of utmost 
importance in the prevention of transmission of these 
highly infectious diseases.
The age range of blood donors in this study was 18 to 
65 years with a mean of 34.6 years. This is similar to 
that in the study of Olokoba et al. (2009) who found 
that their blood donors were in the range of 18 to 61 
years with a mean of 31.3 years. Similarly, the study 
by Khan et al. (2002) showed blood donors in the age 
range of 18 to 60 years while the findings of Muktar et 
al. (2005) in Zaria, Northwestern, Nigeria revealed a 
mean age of 33years even though their age ranged 
from 19 to 42 years. However the donors in Jos, North 
central Nigeria were in the age range of 21-50 years 
(Egah et al., 2004).
Most of the blood donors in this study were males 
(96%). This is similar to the study by Olokoba et al.,
(2009), 96%; Egah et al. (2004), 95%; Muktar et al. 
(2005), 98%; while Nwokediuko et al. (2007) in their 
study in Enugu, South Eastern, Nigeria found that 
91.8% of their donors were males. However, all the 
donors were males in the study of Elfaki et al. (2008) 
among the Sudanese, and in the study of Khan et al.
(2002).
From this study, the overall prevalence of HBsAg 
among voluntary blood donors is 7.26%. This result is 
similar to 7.4% reported by Shittu et al. (2014) at 
Akure, Nigeria; the 8.3% in the work of Muktar et al.
(2005); and the 8.8% found by Matee et al, (1999) in 
Tanzanian donors. This figure is higher than the 1.1% 
found by Ejele et al. (2005) in Niger Delta region of 
Nigeria; the 2.2% found by Bhatti et al. (2007) in 
Pakistani donors; the 2.4% found by Olokoba et al, 
(2009) among voluntary blood donors in Yola, 
Nigeria; the 4.0% found by Abdalla et al. (2005) in 
Kenyan donors and the 2.5% reported by Okonko et 
al. (2012) among intending blood donors in UCH, 
Ibadan, South Western Nigeria. The HBV infection 
rate in this study is however lower than the 14.5% 
reported by Lawal et al. (2009) among blood donors in 
Ibadan; the 20% reported by Alao et al. (2009) among 
prospective blood donors in Otukpo, Benue State; the 
11.0% reported by Oronsanye and Oronsanye, (2004) 
among donors in UBTH, Benue City, Nigeria; the 
18.6% reported by Buseri et al. (2009) among blood 
donors in Osogbo, Nigeria and the 10.0% reported by 
Elfaki et al. (2008) in Sudanese blood donors.
The HCV infection rate of 1.5% found in this study is 
similar to the 1.5% found in the work of Matee et al. 
(1999). This figure is higher than the 0.2% found in 
the work of Abdalla et al. (2005); and the 0.5% found 
in the work of Ejele et al, (2005). The HCV infection 
rate in this study is however lower than the 3.0% 
found by Ezeani et al. (2006) in South-eastern, 
Nigeria; the 3.7% found by Nwokediuko et al. (2007); 
the 3.9% found by Esumeh et al, (2003), the 4.2% 
found in the work of Bhatti et al. (2007) and the 6.0% 
found in the work of Egah et al. (2004). However 
Elfaki et al. (2008) found no case of HCV infection 
among the 260 Sudanese blood donors studied.
The wide differences in the HBV and HCV infection 
rate among the voluntary blood donors in the different 
regions within and outside Nigeria may be due to the 
differences in geographical locations, age range of 
donors, sample size, the period of time the studies 
were carried out, and the different socio-cultural 
practices such as sexual behaviour, marriage practices, 
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circumcision, tattooing, scarifications etc which take 
place in these regions (Olokoba et al., 2009; Shittu et 
al. 2014). Access to healthcare, immunization 
practices, and the laboratory test reagents used for the 
screening may also be contributory factors to the wide 
differences in results (Olokoba et al. 2009).
The highest prevalence of HBV infections was seen in 
donors aged 20-29 years and 30-39 years with an 
infection rate of 2.23% and 2.79% respectively. 
Previous studies by Ado et al. (2010); Adekeye et al.
(2013) and Onwuakor et al. (2014) have also shown 
the highest prevalence to be among these age groups. 
These age groups contain the very active youths in the 
society, and correlates with peak age of sexual 
activity. The highest prevalence of HBV among these 
youths may therefore be attributed to some social vices 
associated with the youths such as unprotected sexual 
activities with multiple partners, tattooing and 
intravenous drug use (Shittu et al., 2014). This again 
explains why hepatitis infection is higher amongst the 
younger age groups in society than in the aged 
(Onwuakor et al., 2014).
The gender distribution showed that the HBV 
infection was higher among males (6.7%) than the 
females (0.56%). Also the prevalence of HCV 
infection was higher in males (1.13%) than in females 
(0.37%). This is probably due to high availability of 
males for blood donation and lifestyle variations 
between the gender groups. This is similar to the 
findings of Adekeye et al., (2013) and Uneke et al.,
(2005) who also reported higher prevalence of these 
infections among males than females. However other 
previous studies by Otegbayo et al., (2003) and 
Pennap et al., (2010) reported higher prevalence of 
HVC among females (16.6%) than males (3.4%). This 
may probably be due to higher sample size from 
females than males. In this study co-infections were 
more prevalent in males (0.56%) than females (0.18). 
Screening for HBsAg alone does not fully reflect the 
epidemiology of the disease as it could indicate a 
carrier state, viral replication or chronic hepatitis. This 
study therefore did not differentiate carriers of HBsAg 
from those with active infection since we did not 
screen for anti HBs antibodies and anti-HBc 
antibodies which are indicators of previous exposure 
to HBV infection. If these markers were assayed for, 
the actual sero-prevalence rate would most probably 
be much higher than the present reported figures. This 
study confirmed the presence of hepatitis B surface 
antigen and HCV among apparently healthy blood 
donors in our community.
The danger of viral hepatitides in voluntary blood 
donors is the risk of transmission of these infections to 
recipients of blood and blood products. It is important 
to take steps to improve our medical facilities and 
diagnosis in the hospital to enable us detects the 
diseases early, reduce their spread and manage 
infected individuals. We recommend the introduction 
of routine screening of blood donors for HCV in 
centres where this is not currently practiced. A strict 
selection criteria for blood donors is emphasized and 
blood transfusion must be highly restricted to those 
that actually need it.
LIMITATIONS
This study has some limitations. In laboratory 
analysis, serology by rapid test kit, is less sensitive 
than amplification assays (liquid phase hybridization, 
antibody capture approach, branched DNA) and DNA 
amplification tests based on the polymerase chain 
reaction (PCR) which are now considered the gold 
standard in the diagnosis of HBV infection. However, 
these tests are very expensive and are not available in 
most centers like ours. Nevertheless, rapid tests kits 
are used as a screening tool in order to identify donors 
that may require confirmation of their status and 
further management. 
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